Tenabene A, Dietemann-Molard A, Kapps M, Pauli G
Service de Pneumologie II, Pavillon Laennec, CHRU de Strasbourg.
Rev Pneumol Clin. 1988;44(6):273-7.
The commercial availability of high-dose inhaled corticosteroid preparations for the treatment of asthma offers an occasion for reviewing the different mechanisms of action of glucocorticoids notably glucocorticoids, notably their interference with lipocortin protein synthesis and arachidonic acid metabolism. A favourable effect on bronchial hyper-reactivity and on delayed hypersensitivity reactions has also been observed. The problems raised by the various preparations responsible for varying degrees of systemic activity, the difficulties inherent in the use of inhalers and the side-effects of these products are discussed. The effectiveness and safety of the current high-dose inhaled preparations are emphasized.
用于治疗哮喘的高剂量吸入性皮质类固醇制剂的商业可得性,为回顾糖皮质激素的不同作用机制提供了契机,尤其是糖皮质激素对脂皮质素蛋白合成和花生四烯酸代谢的干扰。人们还观察到其对支气管高反应性和迟发型超敏反应有有利影响。文中讨论了各种制剂因全身活性程度不同而引发的问题、吸入器使用中固有的困难以及这些产品的副作用。强调了当前高剂量吸入制剂的有效性和安全性。